サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1462907

遺伝子導入技術の世界市場：モード別、用途別、方法別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2024～2032年）

Gene Delivery Technologies Market, By Mode, By Application, By Method, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 311 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
遺伝子導入技術の世界市場：モード別、用途別、方法別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2024～2032年）
出版日: 2024年04月04日
発行: AnalystView Market Insights
ページ情報: 英文 311 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の遺伝子導入技術の市場規模は、2023年に39億1,800万米ドルに達し、2024～2032年にかけてCAGR 14.5%で拡大すると予測されています。

遺伝子導入技術市場 - 市場力学

新技術への投資拡大が市場需要を促進

遺伝子導入の様々な技術の調査、開発、生産をサポートする産業への資金提供や投資の増加は、収益の伸びをさらに加速させます。現在、遺伝子・細胞治療構想の70%はウイルスベクターを使用しており、これが生物学的送達技術の有機的収益成長を牽引しています。増大する需要に対応するため、事業会社はウイルスベクターの生産能力を高めるために大規模な投資を行っています。新しい遺伝子導入システムの開発は、科学界がゲノムレベルで病気の複雑な性質を概説するプロセスを簡素化した、遺伝子改変のためのいくつかの革命的なツールの導入によって促進されてきました。がんやアルツハイマー病などの不治の病を最先端の医薬品で治療するために、ウイルス性、非ウイルス性ともに臨床的に適切なベクターを作製するための継続的な調査が、さらに市場の収益を増大させています。

遺伝子導入技術市場 - 主要洞察

リサーチアナリストの分析によると、世界市場は予測期間（2024～2032年）にCAGR 約14.5%で毎年成長すると予測されています。

市場セグメンテーションに基づくと、生物学的セグメントが予測期間で市場を独占すると予測されます。

用途別では、遺伝子治療が2023年に最大の市場シェアを占めます。

方法別では、生体外セグメントが予測期間中市場をリードすると予測されます。

地域別では、北米が2023年の売上高をリードしています。

遺伝子導入技術市場 - セグメンテーション分析：

世界の遺伝子導入技術市場は、モード、用途、方法、地域に基づいてセグメント化されます。

モードに基づき、市場は生物学的、化学的、物理的に分類されます。生物学的セグメントは、YescartaとKymriahの大成功により、予測期間中市場を独占すると予想されます。最初のウイルスベクターベースの遺伝子治療製品が承認されて以来、ウイルスベクターは多くの注目を集めています。エンドユーザーが主要な送達手段としてウイルスベクターを承認したことは、これらのベクターに基づく研究開発プログラムの数が飛躍的に増加したことからも確認されています。

用途に基づき、市場はインフラ遺伝子治療、細胞治療、ワクチン、調査に分けられます。遺伝子治療は2023年に最大の市場シェアを占め、予測期間中も同じパターンが続くと予想されます。このカテゴリの収益創出は、遺伝子ベースの医薬品の受容性の高まりと、それに伴う臨床研究活動の増加によってもたらされています。世界の遺伝子治療製品の承認率は上昇しており、これがこの分野の拡大をさらに後押ししています。

遺伝子治療法は、生体外（Ex vivo）、生体内（In vivo）、試験管内（In vitro）に分類されます。Ex vivo分野は、免疫原性反応の低減や、患者への細胞再移植前に導入効率を評価できるなど、多くの利点があることから、予測期間中市場をリードすると予想されます。その優れた導入効率やその他の特質により、研究環境において人気の高い選択肢となっています。

遺伝子導入技術市場 - 地理的洞察

地理的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。北米は予測期間中、遺伝子導入技術市場をリードすると見られています。米国では、HIV/AIDS、がん、遺伝性疾患の潜在的治療法としての遺伝子治療の安全性と有効性を評価するために、かなりの数の臨床試験が実施されています。さらに、遺伝子導入技術の製造・販売に携わる最大手企業のかなりの部分が米国に本社を置いています。遺伝子導入技術におけるこの地域の商業的優位性は、いくつかの特徴に起因しています。

遺伝子導入技術市場 - 競合情勢：

公的・私的投資家の間で遺伝子導入技術への関心が高まっており、新規企業の市場参入が加速すると予測されます。市場での地位を向上させるため、大手企業はライセンシング、パートナーシップ、M&Aなど多くの戦略的活動を実施しています。遺伝子導入技術ビジネスではここ数年、注目すべきM&Aが行われています。

目次

第1章 遺伝子導入技術の市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合洞察

第3章 遺伝子導入技術の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 遺伝子導入技術の産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 遺伝子導入技術市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 遺伝子導入技術の市場情勢

  • 遺伝子導入技術市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存プレイヤー分析
    • 新興プレーヤー分析

第7章 遺伝子導入技術市場 - モード別

  • 概要
    • セグメントシェア分析、モード別
    • 生物学的
    • 化学的
    • 物理的

第8章 遺伝子導入技術市場 - 用途別

  • 概要
    • セグメントシェア分析、用途別
    • 遺伝子治療
    • 細胞療法
    • ワクチン
    • 研究

第9章 遺伝子導入技術市場 - 方法別

  • 概要
    • セグメントシェア分析、方法別
    • 生体外
    • 生体内
    • 試験管内

第10章 遺伝子導入技術市場 - 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析 - 遺伝子導入技術産業

  • 競合ダッシュボード
  • 企業プロファイル
    • QIAGEN
    • Vectalys
    • Horizon Discovery Group Co.
    • OriGene Technologies, Inc.
    • Oxford Biomedica
    • SignaGen Laboratories
    • Thermo Fisher Scientific, Inc.
    • Takara Bio Inc.
    • Bio-Rad Laboratories, Inc.
    • System Biosciences llc
    • Hoffmann-La Roche AG
    • Promega Corporation
    • Sirion-Biotech GmbH
    • Catalent Inc.

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Gene Delivery Technologies Market: Mode Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Mode
  • TABLE Global Gene Delivery Technologies Market, by Mode 2019-2032 (USD Million)
  • TABLE Gene Delivery Technologies Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Gene Delivery Technologies Market, by Application 2019-2032 (USD Million)
  • TABLE Gene Delivery Technologies Market: MethodSnapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Method
  • TABLE Global Gene Delivery Technologies Market, by Method2019-2032 (USD Million)
  • TABLE Gene Delivery Technologies Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Gene Delivery Technologies Market, by Region 2019-2032 (USD Million)
  • TABLE North America Gene Delivery Technologies Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Gene Delivery Technologies Market, by Mode, 2019-2032 (USD Million)
  • TABLE North America Gene Delivery Technologies Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Gene Delivery Technologies Market, by Method, 2019-2032 (USD Million)
  • TABLE Europe Gene Delivery Technologies Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Gene Delivery Technologies Market, by Mode, 2019-2032 (USD Million)
  • TABLE Europe Gene Delivery Technologies Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Gene Delivery Technologies Market, by Method, 2019-2032 (USD Million)
  • TABLE Asia Pacific Gene Delivery Technologies Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Gene Delivery Technologies Market, by Mode, 2019-2032 (USD Million)
  • TABLE Asia Pacific Gene Delivery Technologies Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Gene Delivery Technologies Market, by Method, 2019-2032 (USD Million)
  • TABLE Latin America Gene Delivery Technologies Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Gene Delivery Technologies Market, by Mode, 2019-2032 (USD Million)
  • TABLE Latin America Gene Delivery Technologies Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Gene Delivery Technologies Market, by Method, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Gene Delivery Technologies Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Gene Delivery Technologies Market, by Mode, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Gene Delivery Technologies Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Gene Delivery Technologies Market, by Method, 2019-2032 (USD Million)

List of Figures

  • FIGURE Gene Delivery Technologies Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Mode segment market share analysis, 2023 & 2032
  • FIGURE Mode segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Methodsegment market share analysis, 2023 & 2032
  • FIGURE Methodsegment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Gene Delivery Technologies Market share and leading players, 2023
  • FIGURE Europe Gene Delivery Technologies Market share and leading players, 2023
  • FIGURE Asia Pacific Gene Delivery Technologies Market share and leading players, 2023
  • FIGURE Latin America Gene Delivery Technologies Market share and leading players, 2023
  • FIGURE Middle East and Africa Gene Delivery Technologies Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Gene Delivery Technologies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Gene Delivery Technologies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Gene Delivery Technologies Market share analysis by country, 2023
  • FIGURE Germany Gene Delivery Technologies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Gene Delivery Technologies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Gene Delivery Technologies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Gene Delivery Technologies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Gene Delivery Technologies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Gene Delivery Technologies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Gene Delivery Technologies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Gene Delivery Technologies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Gene Delivery Technologies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Gene Delivery Technologies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Gene Delivery Technologies Market share analysis by country, 2023
  • FIGURE India Gene Delivery Technologies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Gene Delivery Technologies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Gene Delivery Technologies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Gene Delivery Technologies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Gene Delivery Technologies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Gene Delivery Technologies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Gene Delivery Technologies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Phillipines Gene Delivery Technologies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Gene Delivery Technologies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Gene Delivery Technologies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Gene Delivery Technologies Market share analysis by country, 2023
  • FIGURE Brazil Gene Delivery Technologies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Gene Delivery Technologies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Gene Delivery Technologies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Gene Delivery Technologies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Gene Delivery Technologies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Gene Delivery Technologies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Gene Delivery Technologies Market share analysis by country, 2023
  • FIGURE Saudi Arabia Gene Delivery Technologies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Gene Delivery Technologies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Gene Delivery Technologies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Gene Delivery Technologies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Gene Delivery Technologies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Gene Delivery Technologies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Gene Delivery Technologies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV2365

REPORT HIGHLIGHT

Gene Delivery Technologies Market size was valued at USD 3,918 Million in 2023, expanding at a CAGR of 14.5% from 2024 to 2032.

The method of transferring foreign genetic material-such as DNA or RNA-into host cells is known as gene delivery. For gene delivery to cause gene expression, the host cell's genome must be reached. For gene delivery to be successful, the foreign gene delivery must stay stable inside the host cell and be able to either multiply on its own or integrate into the genome. To accomplish this, foreign DNA must be created as a component of a vector that is intended to infiltrate the target host cell and transfer the transgene to that cell's genome. Recombinant viruses and synthetic vectors (viral and non-viral) are the two types of vectors that are used to transfer genes.

Gene Delivery Technologies Market- Market Dynamics

Growing investment in new technologies to propel market demand

An increase in funding and investment in the industry that supports the research, development, and production of various techniques of gene transfer accelerates the growth in revenue even more. Currently, 70% of gene and cell therapy initiatives use viral vectors, which is driving organic revenue growth for biological delivery technologies. To meet the growing demand, the operational companies are making large investments to increase the capacity at which they can produce viral vectors. The development of new gene delivery systems has been facilitated by the introduction of several revolutionary tools for genetic modifications that have simplified the process by which the scientific community has outlined the intricate nature of disease at the genomic level. Ongoing research to create clinically appropriate vectors, both viral and non-viral, to cure crippling diseases like cancer, Alzheimer's disease, and others with state-of-the-art medicines, additionally increases the market's revenue.

Gene Delivery Technologies Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.5% over the forecast period (2024-2032)

Based on mode segmentation, the biological segment is expected to dominate the market over the forecast period

Based on the application segmentation, the Gene Therapy held the largest market share in 2023

Based on method segmentation, the Ex vivo segment is expected to lead the market over the projected period

Based on region, North America was the leading revenue generator in 2023

Gene Delivery Technologies Market- Segmentation Analysis:

The Global Gene Delivery Technologies Market is segmented based on Mode, Application, Method, and Region.

Based on the mode, the market is categorized into Biological, Chemical and Physical. The biological segment is expected to dominate the market over the forecast period due to Yescarta's and Kymriah's enormous success. Since the first viral vector-based gene therapy products were approved, viral vectors have attracted a lot of attention. End users' approval of viral vectors as the primary delivery modality has been confirmed by the exponential rise in the number of R&D programs based on these vectors.

Based on the application, the market is divided into Infrastructure Gene Therapy, Cell Therapy, Vaccines and Research. The Gene Therapy held the largest market share in 2023 and is expected to continue the same pattern during the forecast period. The revenue generation in this category has been driven by the increasing acceptability of gene-based medicines and the resulting rise in the number of clinical research activities. Global gene therapy product approval rates are rising, which has further fueled the segment's expansion.

Based on the method, the industry is divided into Ex vivo, In vivo and In vitro. The Ex vivo segment is expected to lead the market over the projected period because of its many benefits, including reduced immunogenic reactions and the capacity to evaluate transduction efficiency before re-implantation of cells into the patient. Its excellent transduction efficiency and other qualities make it a popular choice in research environments.

Gene Delivery Technologies Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to lead the Gene Delivery Technologies market during the forecast period. In the United States, a significant number of clinical trials are being conducted to evaluate the safety and effectiveness of gene therapy as a potential treatment for HIV/AIDS, cancer, and genetic disorders. Additionally, a sizable portion of the largest businesses involved in the production and marketing of gene delivery technology have their headquarters in the United States. The region's commercial dominance in gene delivery technology can be attributed to several characteristics.

Gene Delivery Technologies Market- Competitive Landscape:

It is projected that the growing interest in gene delivery technologies among both public and private investors would hasten the entry of new firms into the market. To improve their market position, the leading companies are also implementing a number of strategic activities, including licensing, partnerships, and mergers and acquisitions. Notable mergers and acquisitions have taken place in the gene delivery technology business in the last few years.

Recent Developments:

In September 2022, Orchard Therapeutics plc, a leader in global gene therapy, and Kyowa Kirin Co., Ltd., a Japan-based global specialty pharmaceutical company (J-GSP) that develops cutting-edge medical solutions using the newest biotechnology, announced they have entered into a definitive agreement under which Kyowa Kirin will acquire Orchard Therapeutics. Through this acquisition, Kyowa Kirin will be able to optimize the value of Libmeldy(R) and effectively expedite the development of Orchard Therapeutics' next-generation MPS programs in addition to its other early research initiatives, which include frontotemporal dementia (FTD) and a severe genetic form of Crohn's disease. Additionally, the combination of Kyowa Kirin's skills, resources, and infrastructure with Orchard Therapeutics' cutting-edge HSC gene therapy platform technology will facilitate the ongoing development of a number of promising biopharmaceutical candidates with the potential to provide transformative value in medical care, including in therapeutic areas and indications like autoimmune diseases and oncology where Kyowa Kirin has extensive experience.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENE DELIVERY TECHNOLOGIES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

QIAGEN

Vectalys

Horizon Discovery Group Co.

OriGene Technologies, Inc.

Oxford Biomedica

SignaGen Laboratories

Thermo Fisher Scientific, Inc.

Takara Bio Inc.

Bio-Rad Laboratories, Inc.

System Biosciences llc

Hoffmann-La Roche AG

Promega Corporation

Sirion-Biotech GmbH

Catalent Inc.

GLOBAL GENE DELIVERY TECHNOLOGIES MARKET, BY MODE- MARKET ANALYSIS, 2019 - 2032

  • Biological
  • Adenovirus
  • Retrovirus
  • AAV
  • Lentivirus
  • Other viruses
  • Non-viral
  • Chemical
  • Physical

GLOBAL GENE DELIVERY TECHNOLOGIES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Gene Therapy
  • Cell Therapy
  • Vaccines
  • Research

GLOBAL GENE DELIVERY TECHNOLOGIES MARKET, BY METHOD- MARKET ANALYSIS, 2019 - 2032

  • Ex vivo
  • In vivo
  • In vitro

GLOBAL GENE DELIVERY TECHNOLOGIES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Gene Delivery Technologies Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Gene Delivery Technologies Market Snippet by Mode
    • 2.1.2.Gene Delivery Technologies Market Snippet by Application
    • 2.1.3.Gene Delivery Technologies Market Snippet by Method
    • 2.1.4.Gene Delivery Technologies Market Snippet by Country
    • 2.1.5.Gene Delivery Technologies Market Snippet by Region
  • 2.2.Competitive Insights

3.Gene Delivery Technologies Key Market Trends

  • 3.1.Gene Delivery Technologies Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Gene Delivery Technologies Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Gene Delivery Technologies Market Opportunities
  • 3.4.Gene Delivery Technologies Market Future Trends

4.Gene Delivery Technologies Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Gene Delivery Technologies Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Gene Delivery Technologies Market Landscape

  • 6.1.Gene Delivery Technologies Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Gene Delivery Technologies Market - By Mode

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Mode, 2023 & 2032 (%)
    • 7.1.2.Biological
      • 7.1.2.1.Adenovirus
      • 7.1.2.2.Retrovirus
      • 7.1.2.3.AAV
      • 7.1.2.4.Lentivirus
      • 7.1.2.5.Other viruses
      • 7.1.2.6.Non-viral
    • 7.1.3.Chemical
    • 7.1.4.Physical

8.Gene Delivery Technologies Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Gene Therapy
    • 8.1.3.Cell Therapy
    • 8.1.4.Vaccines
    • 8.1.5.Research

9.Gene Delivery Technologies Market - By Method

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Method, 2023 & 2032 (%)
    • 9.1.2.Ex vivo
    • 9.1.3.In vivo
    • 9.1.4.In vitro

10.Gene Delivery Technologies Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Gene Delivery Technologies Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Gene Delivery Technologies Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Gene Delivery Technologies Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Gene Delivery Technologies Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Gene Delivery Technologies Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Gene Delivery Technologies Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.QIAGEN
    • 11.2.2.Vectalys
    • 11.2.3.Horizon Discovery Group Co.
    • 11.2.4.OriGene Technologies, Inc.
    • 11.2.5.Oxford Biomedica
    • 11.2.6.SignaGen Laboratories
    • 11.2.7.Thermo Fisher Scientific, Inc.
    • 11.2.8.Takara Bio Inc.
    • 11.2.9.Bio-Rad Laboratories, Inc.
    • 11.2.10.System Biosciences llc
    • 11.2.11.Hoffmann-La Roche AG
    • 11.2.12.Promega Corporation
    • 11.2.13.Sirion-Biotech GmbH
    • 11.2.14.Catalent Inc.

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us